Overview

Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fed Condition

Status:
Not yet recruiting
Trial end date:
2020-10-30
Target enrollment:
Participant gender:
Summary
An open-label, randomized, two-period, two-group, crossover study was conducted in 26 healthy Chinese volunteers under fed conditions to assess the bioequivalence between two formulations of Anastrozole.
Phase:
Phase 1
Details
Lead Sponsor:
The Affiliated Hospital of Qingdao University
Treatments:
Anastrozole